Impact of Psidium Guajava Leaf Extract on Phosphorylated Tau Protein in the Hippocampus of Scopolamine-Induced Alzheimer’s Disease Wistar Rats
Main Article Content
Abstract
The study investigated the effect of Psidium guajava leaf on tau protein accumulation in the CA3 region of the hippocampus of Alzheimer’s disease scopolamine-induced rats. P. guajava leaves were obtained from a botanical garden in Agada 1 Abua, Rivers State, Nigeria. Leaves were washed in running tap water, air dried in shady place for one week then chopped into pieces with the aid of a knife. The chopped leaves were ground into fine particles by means of a mortar and pestle, then extracted using methanol. The study was done in two phases, phase one (acute) lasted for 14 days and phase two (chronic) 84 days. 80 male Wistar rats with weight 100 - 230 g were divided into 5 groups (n = 8). Group 1 served as normal control, group 2 received 1 mg/kg b.wt. i.p. of scopolamine plus distilled water, group 3 received 1 mg/kg scopolamine plus 100 mg/kg b.wt. of P. guajava leaf extract, group 4 received 1 mg/kg scopolamine plus 300 mg/kg b.wt. of P. guajava leaf extract and group 5 received 1 mg/kg scopolamine plus 5 mg/kg donepezil. The phytochemical screening and quantification of the bio-constituents of P. guajava leaf indicated the presence of flavonoids, alkaloid, tannins, saponin, glycoside, carbohydrate and anthraquinone; with flavonoid being the most abundant and anthraquinone the least. Also the methanol proved to be a better solvent for the extraction of the phytochemicals in P. guajava leaf. At the end of the experiment in the two phases, the rats were euthanised with 100 mg/kg b.wt. of ketamine (i.p.), decapitated to remove the brain. Brain tissues for brain-derived neurotrophic factor (BDNF) ELISA assay were rinsed in normal saline then homogenised in phosphate buffer using ceramic mortar and pestle placed on ice then transferred to the lab in ice pack. Brain tissues for histological study were fixed in 10 % neutral buffered formalin. The hippocampus was excised out, sliced into 10 µm thick slides using a microtome and stained in tau antibody immunohistochemistry. Both doses of P. guajava leaf extract significantly reduced tau accumulation in the CA3 region of the hippocampus. However, the 100 mg/kg b.wt. dose had better efficacy as it demonstrated high ameliorative ability comparable to the normal control rats in group 1 in both phases of the study, while the 300 mg/kg b.wt. performed poorly in the acute phase but improved its attenuative effect in the chronic study indicating a time dependent benefit. The extracts also significantly (p < 0.05) increased the BDNF level. Donepezil also improved the level of BDNF and reduced phosphorylated tau but not as compared with the extract.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Alavi Naini, S. M. & Soussi-Yanicostas, N. (2015). Tau hyperphosphorylation and oxidative stress, a critical vicious circle in neurodegenerative taupathies? Oxidative Medicine and Cellular Longevity, 2015: 151979.
Doi: 10.1155/2015/151979
II. Bhatia, V. & Sharma, S. (2020). Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer’s disease. Journal of Neurological Sciences, 421: 117253. Doi: 10.1016/j.jns.2020.117253
III. Bhattacharya, K., Bhattacharjee, A. & Chakraborty, M. (2024). Assessing the potential of Psidium guajava derived phytoconstituents as anticholinesterase inhibitor to combat Alzheimer’s disease: An in-silico and in-vitro approach, Journal of Biomolecular Structure and Dynamics.
Doi:10.1080/07391102.2024.2301930
IV. Breijiyeh, Z. & Karaman, A. (2020). Comprehensive Review of Alzheimer’s disease: causes and treatment. Molecules Review, 25(24): 5789 Doi: 10.3390/molecules25245789
V. Brodowska, K. M. (2017). National flavonoids: classification, potential role, and application of flavonoid analogues. European Journal of Biological Research, 7: 108 – 123
VI. Carvalho, A. M., Heimfarth, L., Pereira, E. W., Oliveira, F. S., Menezes, I. R., Coutinho, H. D., Picot, L., Antoniolli, A. R., Quintans, J. S. & Quintans-Junior, L. J. (2020). Phytol a chlorophyll compound, produce antihyperalgesic, anti-inflammatory and antiarthritic effects: Possible NF-kB pathway involved and reduced levels of the proinflammatory cytokines TNF-α and IL-6. Journal of National Products, 83(4): 1107 – 1117
VII. Chang, H. Y., Sang, T. K. & Chiang, A S. (2018). Untangling the tauopathy for Alzheimer’s disease and Parkinsonism. Journal of Biomedical Science, 25:54. Doi: 10.1186/s12929-018-0457-x
VIII. Chen, S., Townsend, K., Goldberg, T. E., Davies, P., & Conejero-Goldberg, C. (2011). MAPT isoforms: Differentiatial transcriptional profile related to 3R and 4R splice variants. Journal of Alzheimer’s Disease; 22(4): 1313 – 1329
IX. Combs, B., Mueller, R. L., Morfini, G., Brady, S. T. & Kanaan, N. M. (2019). Tau and axonal transport misregulation in tauopathies. Advances in Experimental and Medicinal Biology, 1184(3): 81 – 95
X. Dakappa, S. S., Adhikari, R., Timilsina, S. S. & Sajjekhan, S. (2013). A review on the medicinal plant Psidium guajava Linn (Myrtaceae). Journal of Drug Delivery and Therapeutics., 3(2): 162 - 168
XI. Frozza, R. L., Lourenco, M. V., & De Felice, F. G. (2018). Challenges for Alzheimer’s disease therapy: Insights from novel mechanisms beyond memory defects. Front Neuroscience, 12: 37.
Doi: 10.3389/fnins.2018.00037
XII. Fumagalli, M. & Priori, A. (2012). Functional and clinical neuroanatomy of morality. Brain, 135(7): 2006 – 2021
XIII. Gamblin, T. C., King, M. C., Kuret, J., Berry, R. w. & Binder, L. I. (2000). Oxidative regulation of fatty acid-induced tau polymerization. Biochemistry, 39: 14203 – 14210. Doi: 10.1021/bi0018761
XIV. Gao, Y., Tan, L., Yu, J. T. & Tan, L. (2018). Tau in Alzheimer’s disease: Mechanisms and therapeutic strategies. Journal of Current Alzheimer Research, 15(3): 1005 – 1013
XV. Guo, T., Noble, W. & Hanger, D. P. (2017). Roles of tau protein in health and disease. Acta Neuropathology, 133: 665 – 704,
Doi: 10.1007/s00401-017-1707-9
XVI. Gutierrez, R. M., Mitchel, L. S., & Soli, R. V. (2008). Psidium guajava: A review of its traditional uses, phytochemistry and pharmacplogy. Journal of Ethnopharmacology, 117(1): 1 - 27
XVII. Hock, C., Heese, K., Hulette, C., Rosenberg, C. & Otten, U. (2000). Region-specific neurotrophin imbalance in Alzheimer’s disease: Decreased levels brain-derived neurotrophic factor in hippocampus and cortical areas. Archives Neurology, 57: 846 - 851
XVIII. Hsiao, Y., Hung, H., Chen, S. & Gean, P. (2014). Social interaction rescues memory deficit in an animal model of Alzheimer’s disease by increasing BDNF-dependent hippocampal neurogenesis. The Journal of Neuroscience, 34(49): 16207 – 16219.
Doi: 101523/JNEUOSCI.0747-14.2014
XIX. Huang, E. J. & Reichardt, L. F. (2003). Trk receptors: Roles in neuronal signal transduction. Annual Review Biochemistry, 72: 609 - 642
XX. Iqbal, K., Liu, F., Gong, C. X. & Grundke-Iqbal, I. (2010). Tau in Alzheimer’s disease and related taupathies. Journal of Current Alzheimer Research, 7(8): 656 - 664
XXI. Khaled, M. & Randa, M. H. (2020). Histological, histochemical and immunohistochemical studies of the hippocampus in male New Zealand rabbits. American Association for Anatomy, 304(2): 393 – 399. Doi: https://doi.org/10.1002/ar.24418
XXII. Khanna, M. R., Kovalevich, J., Lee, V. M. Y., Trojanowski, J. Q. & Rrunden, K. R. (2016). Therapeutic strategies for the treatment of tauopathies: Hopes and challenges. Azheimer’s Dementia, 12: 1051 – 1065.
Doi: 10.1016/j.jalz.2016.06.006
XXIII. Kim, Y., Lim, J. & Oh, J. (2024). Taming neuroinflammation in Alzheimer’s disease. The protective role of phytochemicals through the gut-brain axis. Biomedicine and Pharmacotherapy,178:117277.DOI: https://doi.org/10.1016/j.biopha.2024.117277
XXIV. Kumar, A., Singh, A. & Ekavali, A. (2015). A review on Alzheimer’s disease pathophysiology and its management: an update. Pharmacological. Reports. 67(2): 195 – 203
XXV. Laske, C., Stransky, E., Leyhe, T., Eschweiler, G. W., Wittorf, A., Richartz, E., Bartels, M., Buchkremer, G., & Schott, K. (2006). Stage-dependent BDNF serum concentrations in Alzheimer’s disease. Journal of Neural Transmission, 113(9): 1217 – 1224. Doi: 10.1007/s00702-005-0397-y
XXVI. Li, C., Zhang, X., Wang, Y., Cheng, L., Li, C. & Xiang, Y. (2024). The role of IL-1 family of cytokines in the pathogenesis and therapy of Alzheimer’s disease. Inflammopharmacology, 32: 2681 – 2694
XXVII. Liu, J., Li, H., Gong, T., Chen, W., Mao, S., Kong, Y., Yu, J. & Sun, J. (2020). Anti-neuroinflammatory effect of short-chain fatty acid acetate against Alzheimer’s disease via upregulating GPR41 and inhibiting ERK/JNK/NF-kB. Journal of Agriculture, Food and Chemistry, 68: 7152 – 7161
XXVIII. Lorena, C., Ressaissi, A & Serralheiro, M. L. (2022). Bioactives from Psidium guajava leaf decoction: LC-HRMS-MS-Qtof identification, bioactivities and bioavailability evaluation. Food Chemistry Advances, 1: 100003
Doi:10.1016/j.focha.2021.100003
XXIX. Martins, D. (2015). 9 brain regions affected by Alzheimer’s. www.healthcentral.com/slideshow/9-areas-brain-affected-alzheimer’s. 3/1/24
XXX. Medeiro, R., Baglietto-Vargas, D. & LaFerla, F. M. (2011). The role of tau in Alzheimer’s disease and related disorders, Central Nervous System Neuroscience and Therapeutics, 17(5): 514 – 524
XXXI. Miller, E. C., Teravskis, P. J., Dummer. B. W., Zhao, X., Huganir, R. L., & Liao, D. (2014). Tau phosphorylation and tau mislocalization mediate soluble Aβ oligomer-induced AMPA glutamate receptor signalling deficits. European Journal of Neuroscience; 39(7): 1214 – 1224
XXXII. Noble, W., Pooler, A. M. & Hanger, D. P. (2011). Advances in tau-based drug discovery. Expert Opinion Drug Discovery. 6(8): 797 – 810
XXXIII. Okoye, N. (2021). Guava, the sand fruit. www.pharmanewsonline.com/guava-the-sand-fruit/.
XXXIV. Pasinetti, G. (2010). Role of grape seed polyphenols in Alzheimer’s disease neuropathology. Nutrition and Dietary Supplements, 2: 97 - 103
XXXV. Peng, S., Wuu, J., Mufson, E. J. & Fahnestock, M. (2005). Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer’s disease. Journal of Neurochemistry, 93(6): 1412 – 1421
XXXVI. Pisani, A., Paciello, F., De Vecchio, Valeria, Malesci, R., De Corso, E., Cantone, E. & Fetoni, A. R. (2023). The role of BDNF as a biomarker in cognitive and sensory neurodegeneration. Journal of Personalized Medicine, 13(4): 652. Doi: https://doi.org/10.3390/jpm13040652
XXXVII. Pohl, F., Kong, T. & Lin, P. (2018) the potential use of plant natural products and plant extracts with antioxidant properties for the prevention/treatment of neurodegenerative diseases: in vitro, in vivo and clinical trials. Molecules, 23: 3283. Doi: https://doi.org/10.3390/molecules23123283
XXXVIII. Quiroz, Y. T., Sperling, R. A., Norton, D. J., Baena, A., Arboleda-Velasquez, J. F., Cosi, D. et al (2018). Association between amyloid and tau accumulation in young adults with autosomal dominant Alzheimer’s disease. Journal of American Medical Association of Neurology. 75: 548 – 556
XXXIX. Rawat, P., Sehar, U., Bisht, J., Selman, A., Culberson, J. & Reddy, H. P. (2022). Phosphorylated tau in Alzheimer’s disease and other tauopathies. International Journal of Molecular Sciences, 23(21); 12841.
Doi: 10.3390/ijms232112841
XL. Reddy, P. H., Tonk, S., Kumar, S., Vijayan, M., Kandimalla, R., Kuruva, C. S. & Reddy, A. P. (2017). A critical evaluation of the neuroprotective and neurodegenerative microRNAs in AD. Biochemical Biophysical Research Communications, 483(4): 1156 – 1165
XLI. Roberto, G. (2023). Hippocampus: anatomy, functions and connection.
www.kenhub.com/en/library/anatomy/hippocampus-structure-and-functions
XLII. Rojas-Garcia, A., Fernandez-Ochoa, A., Cadiz-Gurrea, L. M., Arraez-Roman, D. & segura-Carretero, A. (2023). Neuroprotective effects of agri-food by-products rich in phenolic compounds. Nutrients, 15(2): 449.
Doi: https://doi.org/10.3390/nu15020449
XLIII. Rouseff, R. L., Onagbola, E. O., Smoot, J. M. & Stelinski, L. L (2008). Sulfur volatiles in guava (Psidium guajava L.) leaves: possible defense mechanism. Journal of Agriculture Food and Chemistry, 56: 8905 – 8910
XLIV. Samluk, L., Ostapczuk, P. & Dziembowska, M. (2022). Long-term mitochondrial stress induces early steps of tau aggregation by increasing reactive oxygen species levels and affecting cellular proteostasis. Molecular Biology of the Cell, 33: mbc, E21 (21): 11 – 0553. Doi: 10.1091/m
XLV. Schinder, A. F. & Poo, M. (2000). The neurotrophin hypothesis for synaptic plasticity. Trends Neuroscience, 23(12):
– 645. Doi: 10.1016/s0166-2236(00)01672-6
XLVI. Shimada, H., Makizako, H., Doi, T., Yoshida, D., Tsut-Sumimoto, K., Anan, Y., Uemura, K., Lee, S., Park, H. & Suzuki, T. (2014). A large cross-sectional observational study of serum BDNF, cognitive function, and mild cognitive impairment in the elderly. Frontier Aging Neuroscience, 6:69.
Doi: 10.3389/fnagi.2014.00069
XLVII. Shishta, E., Rogers, G. T., Blumberg, J. B., Au, R. & Jacques, P. F. (2020). Long-term dietary flavonoid intake and risk of Alzheimer’s disease and related dementias in the Framingham Offspring Cohort. American Journal of Clinical and Nutrition, 112: 343 - 353
XLVIII. Silva, R. F. M. & Pogacnik, L. (2020). Polyphenols from food and natural products: neuroprotective and safety. Antioxidants, 9: 61
XLIX. Silva, W. M. B. da, Santos, J. M. dos, Costa, L. de P., Holanda, L. S.de, Andrade Neto, J. B.,Batista, A .P., Morais, S M. de, & Souza, C. de M. (2022). Potential of the plant Psidium guajava L. against Alzheimer’s disease by reversing scopolamine-induced memory deficit. Research, Society and Development, 11(14), e234111436167
L. Sinsky, J., Pichlerova, K & Hanes, J. (2021). Tau protein interaction partners and their roles in Alzheimer’s disease and other tauopathies. International Molecular Sciences, 22: 9207. Doi: 10.3390/ijms22179207
LI. Sofowara, A. (1993). Medicinal plants and traditional medicine in Africa. Spectrum Books Ltd, Ibadan, Nigeria, P. 289
LII. Srinivasan, K., Sivasubramanian, s., Kumaravel, S. (2013). Phytochemical profile and GC-MS study of Adhatoda vasica leaves. International Journal of Pharmacology and Biological Sciences, 5(1): 714 – 720
LIII. Sun, C., Zhang, S., Ba, S., Dang, J., Ren, Q., Zhu, Y, Liu, K. & Jin, M. (2022). Eucommia ulmoides olive male flower extracts ameliorate Alzheimer’s disease-like pathology in zebrafish via regulating autophagy, acetylcholinesterase, and the dopamine transporter. Frontier in Molecular Neuroscience, 15: 901953
LIV. Tachakittirungrod, S., Okonogi, S. & Chowwanapoonpohn, S. (2007). Study on antioxidant activity of certain plants in Thailand: Mechanism of antioxidant action of guava leaf extract. Food Chemistry, 103(2): 381 – 388
LV. Tachenberg, C. Kulic, L & Nitsch, R. M. (2020). Familial Alzheimer’s disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system. PLos ONE 15(9):e0239584. Doi:10.1371/journal.pone.0239584
LVI. Te-Hsien, L., Kuo-Hsuan, C., Ya-Jen, C., Zheng-Kui, W., Yin-Chieh, S., Wenwei, L., Guey-Jen, L. & Chiung-Mei, C. (2022). Neuroprotective action of coumarin derivatives through the activation of TRKB-CREB-BDNF pathway and reduction of caspase activity in neuronal cells expressing pro-aggregated tau protein. International Journal of Molecular Sciences, 23(21): 12734.
Doi: https://doi.org/10.3390/ijms232112734
LVII. Thakur, A. K., Kamboj, P., Goswami, K, & Ahuj, K. (2018). Pathophysiology and management of Alzheimer’s disease: An overview. Journal of Analytical & Pharmaceutical Research, 9(2): 226 – 235. Doi: 10.15406/japlr.2018.07.00230
LVIII. Themozhi, S. & Rajan, S. (2015). GC-MS analysis of bioactive compounds in Psidium guajava leaves. Journal of Pharmacognosy and Phytochemistry, 3(5): 162 – 166
LIX. Trease, G. E. & Evans, W. C. (1989). Pharmacognosy. Ed 11, Brailliar Tiridel can. Macmillian publishers
LX. Ullah, A., Munir, S., Badshah, S. L., Khan, N., Ghani, L., Poulson, B. G., Emwas, A. H. & Jaremko, M. (2020). Important flavonoids and their role as a therapeutic agent. Molecules, 25: 5243
LXI. Usen, D. U. & Enogieru, A. B. (2023). Aluminium Chloride induced prefrontal cortex toxicity in wistar rats: Evidence from pretreatment with aqueous Psidium guajava leaf extract. Dutse Journal of Pure and Applied Sciences, 9(3): 1 – 10
LXII. Walton, M. R. & Dragunow, I. (2000). Is CREB a key to neuronal survival? Trends Neuroscience, 23(2): 48 – 53. Doi: 10.1016/s0166-2236(99)01500-3
LXIII. Xue, B., Waseem, A., Zhu, Z., Alshahrani, M., Nazam, N., Anjum, F., Habib, H. A., Rafeeq, M. M., Nazam, F. & Sharma, M. (2022). Brain-derived neurotrophic factor: A connecting link between nutrition, lifestyle and Alzheimer’s disease. Frontiers in Neuroscience, 16: 925991 Doi:10.3389/fnins.2022.925991.
LXIV. Zhu, X., Raina, A. K., Rottkamp, C. A., Aliev, G., Perry, G., Boux, H. & Smith, M. A. (2001). Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer’s disease. Journal of Neurochemistry, 76: 435 – 441.
Doi: 10.1046/j.1471 – 4159.2001.00046.x